Covered recipient · General Payments record
ELIZABETH HUTSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$500.12
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $468.11 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $294.38 | 19 |
| Acerta Pharma LLC | $74.61 | 5 |
| Phathom Pharmaceuticals, Inc. | $24.32 | 1 |
| ITI, Inc. | $22.62 | 1 |
| Novo Nordisk AS | $21.55 | 1 |
| Amgen Inc. | $16.02 | 1 |
| Lilly USA, LLC | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.59 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960255 | CMS |
| ABBVIE INC. | $21.59 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960257 | CMS |
| ABBVIE INC. | $16.07 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960259 | CMS |
| ABBVIE INC. | $21.94 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960261 | CMS |
| ABBVIE INC. | $22.38 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960263 | CMS |
| ABBVIE INC. | $8.51 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960265 | CMS |
| ABBVIE INC. | $12.19 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960267 | CMS |
| ABBVIE INC. | $6.38 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960269 | CMS |
| ABBVIE INC. | $5.03 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960271 | CMS |
| ABBVIE INC. | $7.84 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960273 | CMS |
| ABBVIE INC. | $33.91 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960275 | CMS |
| ABBVIE INC. | $24.96 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960277 | CMS |
| ABBVIE INC. | $20.90 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960279 | CMS |
| ABBVIE INC. | $13.72 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960281 | CMS |
| ABBVIE INC. | $9.06 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960283 | CMS |
| ABBVIE INC. | $14.00 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960285 | CMS |
| ABBVIE INC. | $12.00 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960287 | CMS |
| ABBVIE INC. | $22.53 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960289 | CMS |
| ABBVIE INC. | $15.78 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103960291 | CMS |
| Amgen Inc. | $16.02 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117283651 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105807882 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.53 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105615359 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.22 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104575442 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.43 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105305083 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.12 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104497768 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22.62 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245341 | CMS |
| Lilly USA, LLC | $14.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136158431 | CMS |
| Novo Nordisk Inc | $21.55 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096934431 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.32 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151074864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.